[go: up one dir, main page]

SG11201802777XA - Compositions and methods for reducing ice crystal formation - Google Patents

Compositions and methods for reducing ice crystal formation

Info

Publication number
SG11201802777XA
SG11201802777XA SG11201802777XA SG11201802777XA SG11201802777XA SG 11201802777X A SG11201802777X A SG 11201802777XA SG 11201802777X A SG11201802777X A SG 11201802777XA SG 11201802777X A SG11201802777X A SG 11201802777XA SG 11201802777X A SG11201802777X A SG 11201802777XA
Authority
SG
Singapore
Prior art keywords
compositions
methods
crystal formation
ice crystal
reducing ice
Prior art date
Application number
SG11201802777XA
Inventor
Xiaoxi Wei
Original Assignee
X Therma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by X Therma Inc filed Critical X Therma Inc
Publication of SG11201802777XA publication Critical patent/SG11201802777XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A23B2/762—Organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/80—Freezing; Subsequent thawing; Cooling
    • A23B2/85—Freezing; Subsequent thawing; Cooling with addition of or treatment with chemicals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B4/00—Preservation of meat, sausages, fish or fish products
    • A23B4/14—Preserving with chemicals not covered by groups A23B4/02 or A23B4/12
    • A23B4/18—Preserving with chemicals not covered by groups A23B4/02 or A23B4/12 in the form of liquids or solids
    • A23B4/20—Organic compounds; Microorganisms; Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G9/00—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor
    • A23G9/32—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G9/00—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor
    • A23G9/32—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds
    • A23G9/38—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds containing peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
    • A23L13/40—Meat products; Meat meal; Preparation or treatment thereof containing additives
    • A23L13/42—Additives other than enzymes or microorganisms in meat products or meat meals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88—Polyamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q90/00—Cosmetics or similar toiletry preparations for specific uses not provided for in other groups of this subclass
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10—Alpha-amino-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/16—Nitrogen-containing compounds
    • C08K5/20—Carboxylic acid amides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L77/00—Compositions of polyamides obtained by reactions forming a carboxylic amide link in the main chain; Compositions of derivatives of such polymers
    • C08L77/04—Polyamides derived from alpha-amino carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00—Materials not provided for elsewhere
    • C09K3/18—Materials not provided for elsewhere for application to surfaces to minimize adherence of ice, mist or water thereto; Thawing or antifreeze materials for application to surfaces
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Combustion & Propulsion (AREA)
  • Materials Engineering (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dairy Products (AREA)
  • Confectionery (AREA)
  • Storage Of Fruits Or Vegetables (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SG11201802777XA 2015-10-14 2016-10-13 Compositions and methods for reducing ice crystal formation SG11201802777XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562241588P 2015-10-14 2015-10-14
PCT/US2016/056852 WO2017066454A2 (en) 2015-10-14 2016-10-13 Compositions and methods for reducing ice crystal formation

Publications (1)

Publication Number Publication Date
SG11201802777XA true SG11201802777XA (en) 2018-05-30

Family

ID=58518569

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201802777XA SG11201802777XA (en) 2015-10-14 2016-10-13 Compositions and methods for reducing ice crystal formation

Country Status (13)

Country Link
US (4) US9986733B2 (en)
EP (1) EP3370518B1 (en)
JP (2) JP7011830B2 (en)
KR (1) KR102686073B1 (en)
CN (1) CN108347916B (en)
AU (1) AU2016338410B2 (en)
CA (1) CA3001065A1 (en)
ES (1) ES2958531T3 (en)
HK (1) HK1258922A1 (en)
IL (1) IL258648A (en)
MX (1) MX2018004518A (en)
SG (1) SG11201802777XA (en)
WO (1) WO2017066454A2 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201802777XA (en) 2015-10-14 2018-05-30 X Therma Inc Compositions and methods for reducing ice crystal formation
US11110176B2 (en) 2016-11-25 2021-09-07 The Board Of Trustees Of The California State University Composition and method for the protection of proteins, cell components and cells during temperature stress
JP7212373B2 (en) 2017-04-12 2023-01-25 エックス－サーマ インコーポレイテッド Novel peptoid polymers and methods of use
CN118680161A (en) 2017-04-12 2024-09-24 先时迈纳米生物科技股份有限公司 New supercooling method for preserving biological samples
GB201708999D0 (en) 2017-06-06 2017-07-19 Univ Warwick Recrystallization Inhibitor
FR3072246B1 (en) * 2017-10-13 2020-06-12 Biodesiv Efnium ANTIMICROBIAL POLYMER FOR ANIMAL SEEDS
WO2019099922A1 (en) * 2017-11-16 2019-05-23 X-Therma, Inc. Cavity-containing oligomers and polymers effective in cryopreservation
CN108359613B (en) * 2018-05-14 2022-04-29 安发（福建）生物科技有限公司 Cordyceps sinensis antifreeze agent and ultralow-temperature preservation and recovery method based on antifreeze agent
CN108910010A (en) * 2018-06-25 2018-11-30 浙江工业大学 A kind of method of the green safe preservation aquatic products in sea
CN108795392B (en) * 2018-06-25 2020-10-02 浙江工业大学 Non-freezing liquid for food preservation
US20220117221A1 (en) * 2019-01-17 2022-04-21 Nagase & Co., Ltd. Cell cryopreservation solution
AR118008A1 (en) 2019-02-07 2021-09-08 Vitricell Sa COMPOSITIONS FOR CRYOPRESERVATION OF A BIOLOGICAL MATERIAL
WO2020207151A1 (en) * 2019-04-09 2020-10-15 北京大学第三医院（北京大学第三临床医学院） Cryopreservation solution without dmso, preparation method therefor and application thereof
CN111789099B (en) * 2019-04-09 2022-09-06 北京大学第三医院 Application of cryopreservation liquid containing peptide compounds in cryopreservation of oocytes or embryos
WO2020207152A1 (en) * 2019-04-09 2020-10-15 中国科学院化学研究所 Serum-free cryopreservation solution and preparation method and application thereof
CN111789102B (en) * 2019-04-09 2022-07-12 北京大学第三医院 Application of thawing solution in thawing frozen and preserved oocyte or embryo
KR102731775B1 (en) * 2019-04-09 2024-11-18 페킹 유니버시티 서드 호스피탈 Thawing solution and its preparation method and application
US20220192179A1 (en) * 2019-04-09 2022-06-23 Institute Of Chemistry, Chinese Academy Of Sciences Biomimetic ice-inhibiting material and cryopreservation solution comprising same
CN110231821B (en) * 2019-06-03 2022-05-31 哈尔滨工程大学 Improved self-adaptive zero-space behavior fusion method for multi-robot formation
CN110408052B (en) * 2019-07-09 2022-03-25 长春工业大学 A kind of fish antifreeze protein biomimetic freeze-resistant sticky and tough hydrogel and preparation method thereof
CN110800733A (en) * 2019-11-21 2020-02-18 武汉光谷中源协和细胞基因科技有限公司 A kind of cryopreservation solution and kit for umbilical cord mesenchymal stem cells
EP3831203A1 (en) 2019-12-03 2021-06-09 Seoul National University R & DB Foundation Composition for inhibiting ice recrystallization
US11800864B2 (en) 2019-12-03 2023-10-31 Seoul National University R&Db Foundation Composition for inhibiting ice recrystallization
KR102274195B1 (en) 2019-12-04 2021-07-08 고려대학교 산학협력단 Anti-freeze composition comprising self-assembly compound
US20210267224A1 (en) * 2020-02-27 2021-09-02 Independent Quality Foods, Llc Composition and process for long term preservation of food
CN113383766A (en) * 2020-03-12 2021-09-14 中国科学院化学研究所 Freezing storage liquid for stem cell freezing storage and preparation method thereof
CN111345282A (en) * 2020-03-17 2020-06-30 广东万海细胞生物科技有限公司 A kind of cell cryopreservation solution and cryopreservation method
CN111802440A (en) * 2020-07-17 2020-10-23 青岛贵仕生物科技有限公司 Fresh-keeping storage method of freeze-dried marine fish food
CN112056386B (en) * 2020-09-03 2022-10-28 余姚谷满仓食品有限公司 Processing technology of quick-frozen broccoli
CN112400863A (en) * 2020-11-26 2021-02-26 成都康景生物科技有限公司 Clinical NK cell cryopreservation liquid and cryopreservation method
KR102454226B1 (en) * 2020-12-04 2022-10-14 고려대학교 산학협력단 Cryoprotective composition comprising dna nanostructures and methods of using same
EP4197988A1 (en) * 2021-12-17 2023-06-21 Raytheon Technologies Corporation Freeze drying of composites for filament spreading
WO2024020404A1 (en) * 2022-07-18 2024-01-25 21St Century Medicine, Inc. Method and apparatus for ultra-rapid preparation of corneas for vitrification
CN116138247A (en) * 2023-01-31 2023-05-23 清华大学 Combination reagent for cryoprotection of animal tissue and its application and method
CN116491500A (en) * 2023-05-09 2023-07-28 博生吉安科细胞技术有限公司 A kind of NK cell cryopreservation liquid and its preparation method and application

Family Cites Families (211)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672037A (en) * 1983-11-03 1987-06-09 American Type Culture Collection Method of culturing freeze-dried microorganisms
US5071741A (en) * 1988-04-18 1991-12-10 Cryolife, Inc. Cryoprotective agent and its use in cryopreservation of cellular matter
US5223015A (en) * 1988-07-07 1993-06-29 Shin Charles C H Cryoprotectant composition
US6075121A (en) 1990-05-15 2000-06-13 Chiron Corporation Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such
DK51092D0 (en) 1991-05-24 1992-04-15 Ole Buchardt OLIGONUCLEOTIDE ANALOGUE DESCRIBED BY PEN, MONOMERIC SYNTHONES AND PROCEDURES FOR PREPARING THEREOF, AND APPLICATIONS THEREOF
US5766855A (en) 1991-05-24 1998-06-16 Buchardt, Deceased; Ole Peptide nucleic acids having enhanced binding affinity and sequence specificity
US20030105286A1 (en) 1991-05-24 2003-06-05 Michael Egholm Linked peptide nucleic acids
US6441130B1 (en) 1991-05-24 2002-08-27 Isis Pharmaceuticals, Inc. Linked peptide nucleic acids
US7223833B1 (en) 1991-05-24 2007-05-29 Isis Pharmaceuticals, Inc. Peptide nucleic acid conjugates
US5641625A (en) 1992-05-22 1997-06-24 Isis Pharmaceuticals, Inc. Cleaving double-stranded DNA with peptide nucleic acids
US5539082A (en) 1993-04-26 1996-07-23 Nielsen; Peter E. Peptide nucleic acids
US5714331A (en) 1991-05-24 1998-02-03 Buchardt, Deceased; Ole Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
US5719262A (en) 1993-11-22 1998-02-17 Buchardt, Deceased; Ole Peptide nucleic acids having amino acid side chains
US6414112B1 (en) 1991-05-24 2002-07-02 Ole Buchardt Peptide nucleic acids having 2,6-diaminopurine nucleobases
US6713602B1 (en) 1991-05-24 2004-03-30 Ole Buchardt Synthetic procedures for peptide nucleic acids
US6228982B1 (en) 1992-05-22 2001-05-08 Benget Norden Double-stranded peptide nucleic acids
US6451968B1 (en) 1991-05-24 2002-09-17 Isis Pharmaceuticals, Inc. Peptide nucleic acids
US20030232355A1 (en) 1992-05-22 2003-12-18 Isis Pharmaceuticals, Inc. Double-stranded peptide nucleic acids
US6770738B1 (en) 1992-05-22 2004-08-03 Isis Pharmaceuticals, Inc. Higher order structure and binding of peptide nucleic acids
DE69332524T2 (en) 1992-09-24 2003-04-24 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Synthesis of N-substituted oligomers
US5831005A (en) * 1992-09-24 1998-11-03 Chiron Corporation Synthesis of N-substituted oligomers
US5877278A (en) 1992-09-24 1999-03-02 Chiron Corporation Synthesis of N-substituted oligomers
EP0618191A1 (en) 1993-04-02 1994-10-05 AMERSHAM INTERNATIONAL plc Metal chelating compounds
US6350853B1 (en) 1993-04-26 2002-02-26 Peter E. Nielsen Conjugated peptide nucleic acids having enhanced cellular uptake
US7825215B1 (en) 1993-04-26 2010-11-02 Peter E. Nielsen Substituted nucleic acid mimics
US5840485A (en) 1993-05-27 1998-11-24 Selectide Corporation Topologically segregated, encoded solid phase libraries
ATE366741T1 (en) 1993-05-27 2007-08-15 Aventis Pharma Inc TOPOLOGICALLY SEPARATE, SOLID-PHASE CODING LIBRARIES
US5608110A (en) 1993-06-15 1997-03-04 Bracco International B.V. Heteroatom-bearing ligands and metal complexes thereof
CA2168964C (en) 1993-09-30 2000-08-22 Yoshimi Sato Novel peptide, and platelet aggregation-inhibiting agents, blood coagul ation-inhibiting agents for extracorporeal circulation, cell adhesion-inhibiting agents, tumor metastasis-inhibiting agents, agents for protecting platelet preparations for blood transfusion, platelet preparations and platelet preparation packs for transfusion using said novel peptides
US6710164B1 (en) 1993-11-22 2004-03-23 Peter E. Nielsen Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
AT401930B (en) 1993-12-27 1996-12-27 Chemie Linz Gmbh Process for the preparation of n-substituted glycine esters and process for synthesizing indigo from the glycine esters prepared in this way
KR100360639B1 (en) 1994-03-09 2003-01-30 코르텍, 인크. Bradykinin Antagonist Peptides Incorpoating N-Substituted Glycines
US6025472A (en) 1994-12-21 2000-02-15 Corvas International, Inc. N-substituted glycine derivatives as enzyme inhibitors
US5696231A (en) 1994-12-21 1997-12-09 Corvas International, Inc. N-substituted glycine derivatives as enzyme inhibitors
US5481020A (en) 1994-12-30 1996-01-02 Chiron Corporation Opiate receptor ligands
US6169073B1 (en) 1995-02-16 2001-01-02 Bayer Corporation Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function
GB9508195D0 (en) 1995-04-20 1995-06-07 Univ British Columbia Novel biologically active compounds and compositions,their use and derivation
US6248713B1 (en) 1995-07-11 2001-06-19 Biogen, Inc. Cell adhesion inhibitors
DE19538246C2 (en) * 1995-10-13 1999-01-21 Bayer Ag A cooling medium for use at elevated operating temperatures
US6096710A (en) 1995-11-17 2000-08-01 The Regents Of The University Of California Collagen-like peptoid residue-containing structures
US6239108B1 (en) 1996-07-11 2001-05-29 Biogen, Inc. Cell adhesion inhibitors
JP2001501593A (en) 1996-08-08 2001-02-06 アミリン・ファーマシューティカルズ，インコーポレイテッド Methods for regulating gastrointestinal motility
US6251433B1 (en) 1996-08-13 2001-06-26 Chiron Corporation Polycationic polymers
CA2277112C (en) 1997-01-07 2008-08-26 Amylin Pharmaceuticals, Inc. Use of exendins and agonists thereof for the reduction of food intake
US6841657B2 (en) 1997-04-17 2005-01-11 Whitehead Institute For Biomedical Research Inhibitors of HIV membrane fusion
US6033631A (en) 1997-04-28 2000-03-07 Chiron Corporation Synthesizer with reagent recycling
KR20010012809A (en) 1997-05-21 2001-02-26 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 Composition and method for enhancing transport across biological membranes
US6107470A (en) 1997-05-29 2000-08-22 Nielsen; Peter E. Histidine-containing peptide nucleic acids
US5989925A (en) 1997-06-27 1999-11-23 Serex, Inc. Antibody to and assay for peptide linked-pyridinoline as indicator of bone resorption level
FR2766179B1 (en) 1997-07-16 2000-03-17 Oreal NOVEL CATIONIC OXIDATION BASES, THEIR USE FOR OXIDATION DYEING OF KERATINIC FIBERS, TINCTORIAL COMPOSITIONS AND DYEING METHODS
US7157555B1 (en) 1997-08-08 2007-01-02 Amylin Pharmaceuticals, Inc. Exendin agonist compounds
TW460478B (en) 1997-08-15 2001-10-21 Chugai Pharmaceutical Co Ltd Phenethylamine derivatives
US7220721B1 (en) 1997-11-14 2007-05-22 Amylin Pharmaceuticals, Inc. Exendin agonist peptides
MXPA00004670A (en) 1997-11-14 2003-07-14 Amylin Pharmaceuticals Inc Novel exendin agonist compounds.
US6001815A (en) 1997-12-25 1999-12-14 Nisshin Flour Milling Co., Ltd. Depsipeptides containing N-substituted glycine residue
US6232494B1 (en) 1998-02-12 2001-05-15 Monsanto Company Process for the preparation of N-(phosphonomethyl)glycine by oxidizing N-substituted N-(phosphonomethyl)glycine
US6703359B1 (en) 1998-02-13 2004-03-09 Amylin Pharmaceuticals, Inc. Inotropic and diuretic effects of exendin and GLP-1
US6238637B1 (en) 1998-02-26 2001-05-29 Monsanto Company Process and apparatus for preparation of phosphorus oxyacids from elemental phosphorus
US6468977B1 (en) 1998-03-02 2002-10-22 Apotex Inc. Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
EP1075455A2 (en) 1998-05-08 2001-02-14 Chiron Corporation Method and device for nonsynthetic deconvolution
JP4522587B2 (en) 1998-12-01 2010-08-11 ファイロニックス ファーマシューティカルズ， インコーポレイテッド Methods for introducing heterologous cells into fish
US6458766B1 (en) 1998-12-15 2002-10-01 The Regents Of The University Of California Halovir, an antiviral marine natural product, and derivatives thereof
US7399489B2 (en) 1999-01-14 2008-07-15 Amylin Pharmaceuticals, Inc. Exendin analog formulations
US6924264B1 (en) 1999-04-30 2005-08-02 Amylin Pharmaceuticals, Inc. Modified exendins and exendin agonists
US6506724B1 (en) 1999-06-01 2003-01-14 Amylin Pharmaceuticals, Inc. Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
EP1064938A1 (en) 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
US20040258750A1 (en) 1999-06-28 2004-12-23 Gerard Alaux Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
JP2003503479A (en) 1999-07-06 2003-01-28 バーテックス ファーマシューティカルズ インコーポレイテッド N-substituted glycine derivatives
US6677445B1 (en) 1999-08-27 2004-01-13 Chiron Corporation Chimeric antisense oligonucleotides and cell transfecting formulations thereof
US6783929B1 (en) 1999-11-02 2004-08-31 Chiron Corporation Biological sample component purification and differential display
US6306204B1 (en) 1999-11-24 2001-10-23 Xerox Corporation Ink jet ink compositions and printing processes
WO2001060837A2 (en) 2000-02-16 2001-08-23 Northwestern University Polypeptoid pulmonary surfactants
US6376708B1 (en) 2000-04-11 2002-04-23 Monsanto Technology Llc Process and catalyst for dehydrogenating primary alcohols to make carboxylic acid salts
US20040241176A1 (en) * 2000-04-27 2004-12-02 Ap Cells. Inc. Method of producing membrane vesicles
US6812237B2 (en) 2000-05-15 2004-11-02 Novartis Ag N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
JP2003536073A (en) 2000-06-05 2003-12-02 カイロン コーポレイション Microarrays for performing proteomics analysis
US7153682B2 (en) 2000-06-05 2006-12-26 Chiron Corporation Microarrays on mirrored substrates for performing proteomic analyses
US7148058B2 (en) 2000-06-05 2006-12-12 Chiron Corporation Protein microarrays on mirrored surfaces for performing proteomic analyses
WO2002004417A1 (en) 2000-07-06 2002-01-17 Pharmacia Corporaion Process for the preparation of derivatives of 4-amino-3-hydroxypyrrole-2-carboxylic acid
WO2002010186A1 (en) 2000-07-27 2002-02-07 California Institute Of Technology A rapid, quantitative method for the mass spectrometric analysis of nucleic acids for gene expression and genotyping
US6608026B1 (en) 2000-08-23 2003-08-19 Board Of Regents, The University Of Texas System Apoptotic compounds
ES2169690B1 (en) 2000-10-06 2004-03-16 Diverdrugs Sl QUARTERS OF N-ALQUILGLICINA CAPABLE OF PROTECTING NEURONS AGAINST EXCITOTOX AGGRESSIONS, AND COMPOSITIONS CONTAINING THEM.
ES2169691B1 (en) 2000-10-11 2004-03-16 Diverdrugs Sl N-ALQUILGLYCIN QUARTERS ABLE TO BLOCK THE RESPONSE TO CHEMICAL SUBSTANCES, THERMAL STIMULES OR MEDIATORS OF THE INFLAMMATION OF NEURONAL RECEPTORS, AND COMPOSITIONS CONTAINING THEM.
EP1404867B1 (en) 2000-12-23 2008-02-27 Novartis Vaccines and Diagnostics, Inc. Oligonucleotide transfection screening method
WO2002062823A2 (en) 2001-02-02 2002-08-15 Yale University Peptides for facilitating composite receptor expression and translocation of macromolecules
WO2002081637A2 (en) 2001-04-06 2002-10-17 Chiron Corporation Peptides incorporating chemoselective functionalities
US7163934B2 (en) 2001-05-04 2007-01-16 Corcept Therapeutics, Inc. Methods for treating delirium glucocorticoid receptor-specific antagonists
EP1436080A2 (en) 2001-10-18 2004-07-14 Monsanto Technology LLC Process and catalyst for dehydrogenating primary alcohols to make carboxylic acid salts
US7026166B2 (en) 2002-01-22 2006-04-11 Chiron Corporation Fluorogenic dyes
EP1504111A4 (en) 2002-04-19 2005-11-23 California Inst Of Techn PEPTIDES NUCLEIC ACID PEPTIDE DISPLAY LIBRARS CONTAINING UNNATURELY AMINO-ACID-RESISTANT AND METHOD FOR THE PRODUCTION THEREOF
US7019094B2 (en) 2002-05-31 2006-03-28 Biotage Ab Intermediate products, methods for their preparation and use thereof
US7736909B2 (en) 2003-01-09 2010-06-15 Board Of Regents, The University Of Texas System Methods and compositions comprising capture agents
US7704756B2 (en) 2003-01-21 2010-04-27 Novartis Vaccines And Diagnostics, Inc. Fluorogenic dyes
US7084116B2 (en) 2003-03-10 2006-08-01 Dynogen Pharmaceuticals, Inc. Methods for treating lower urinary tract disorders and the related disorders vulvodynia and vulvar vestibulitis using Cav2.2 subunit calcium channel modulators
US20040192564A1 (en) 2003-03-25 2004-09-30 Vasudevan Balasubramaniam Bimodal gear lubricant formulation
EP1723165A1 (en) 2003-04-15 2006-11-22 MERCK PATENT GmbH Identification of n-alkylglycine trimers for induction of apoptosis
WO2004096839A1 (en) 2003-05-02 2004-11-11 Polyphor Ag Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
DE10320453A1 (en) 2003-05-08 2004-11-25 Morphochem AG Aktiengesellschaft für kombinatorische Chemie New Actinonin Bioisosteres
JP2006527674A (en) 2003-06-18 2006-12-07 フジ　フォト　フィルム　ビー．ブイ． Inkjet recording medium
EP1995256A1 (en) 2003-07-30 2008-11-26 University of Pittsburgh of the Commonwealth System of Higher Education EPHA2 T-cell epitope agonists and uses therefor
US20060035242A1 (en) 2004-08-13 2006-02-16 Michelitsch Melissa D Prion-specific peptide reagents
KR101166012B1 (en) 2003-08-13 2012-07-23 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 Prion-specific peptide reagents
US7750180B2 (en) 2003-08-22 2010-07-06 Monsanto Technology Llc Process for the preparation of N-phosphonomethylglycine and derivatives thereof
CA2539274C (en) * 2003-09-16 2016-03-15 21St Century Medicine, Inc. Methods and compositions for the cryopreservation of organs
WO2005032837A1 (en) 2003-10-03 2005-04-14 Fuji Photo Film B.V. Recording medium
MXPA06006892A (en) 2003-12-19 2008-02-13 Novartis Vaccines & Diagnostic Cell transfecting formulations of small interfering rna, related compositions and methods of making and use.
WO2005122379A2 (en) 2004-05-27 2005-12-22 The Regents Of The University Of California Alpha-4 beta-1 integrin ligands for imaging and therapy
US7740861B2 (en) 2004-06-16 2010-06-22 University Of Massachusetts Drug delivery product and methods
US7879866B2 (en) 2004-07-19 2011-02-01 Dorte Xenia Gram Inhibition of the activity of the capsaicin receptor in the treatment of obesity or obesity-related diseases and disorders
US20060142319A1 (en) 2004-12-14 2006-06-29 Bang-Chi Chen Pyridyl-substituted spiro-hydantoin crystalline forms and process
US20090011946A1 (en) 2004-12-20 2009-01-08 Kalinex Use of Sequence Specific Polymers in Chemical Detection
BRPI0606529A2 (en) 2005-01-13 2009-06-30 Novartis Vaccines & Diagnostic method for detecting the presence of a pathogenic prion in a sample and control and substitute for use in a prion detection assay
EP1888103B1 (en) 2005-04-11 2012-03-21 Amylin Pharmaceuticals, Inc. Use of glp-1, exendin and agonists thereof to delay or prevent cardiac remodeling
GB0507537D0 (en) 2005-04-14 2005-05-18 Univ Durham Protein resistant surfaces
DE102005024017A1 (en) 2005-05-25 2006-11-30 Merck Patent Gmbh quinazolinones
KR20190084136A (en) * 2005-08-05 2019-07-15 아라임 파마슈티칼즈, 인크. Tissue protective peptides and uses thereof
US20070054298A1 (en) 2005-08-12 2007-03-08 Kent Kirshenbaum Methods for enzyme-mediated coupling of oligomers
US20070042041A1 (en) 2005-08-17 2007-02-22 Board Of Trustees Of The University Of Arkansas Drug-surfactant complexes for sustained release
EP1931695B1 (en) 2005-09-09 2013-04-10 Novartis AG Prion-specific peptoid reagents
WO2007070509A2 (en) 2005-12-13 2007-06-21 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Epithelial sodium channel inhibiting agents and uses therefor
UA95788C2 (en) 2005-12-15 2011-09-12 Ф. Хоффманн-Ля Рош Аг Fused pyrrole derivatives
EP3205644A1 (en) 2005-12-29 2017-08-16 Celtaxsys Inc. Diamine derivatives as inhibitors of leukotriene a4 hydrolase
TW200745025A (en) 2005-12-29 2007-12-16 Schering Ag Amide inhibitors of leukotriene A4 hydrolase
WO2007076555A2 (en) 2005-12-29 2007-07-05 Aechelon Technology, Inc. A location based wireless collaborative environment with a visual user interface
US8524663B2 (en) 2006-03-03 2013-09-03 New York University Method for site-specific polyvalent display on polymers
TW200808793A (en) 2006-03-07 2008-02-16 Smithkline Beecham Corp Prolyl hydroxylase inhibitors
JP2009537558A (en) 2006-05-16 2009-10-29 スミスクライン・ビーチャム・コーポレイション Prolyl hydroxylase inhibitor
PE20080209A1 (en) 2006-06-23 2008-05-15 Smithkline Beecham Corp GLYCINE DERIVATIVES AS PROLYL HYDROXYLASE INHIBITORS
DE102006039615A1 (en) 2006-08-24 2008-03-13 Leibniz-Institut Für Pflanzenbiochemie Ester Elongation Method for the Sequence-Driven Construction of Alternate Peptide Peptoid Polymers (Peptide Peptoid Polymers)
KR100905901B1 (en) 2006-09-07 2009-07-02 웅진코웨이주식회사 Amine aqueous solution for forming an active layer of polyamide reverse osmosis composite membrane, polyamide reverse osmosis composite membrane prepared thereby, and preparation method thereof
WO2008031016A2 (en) 2006-09-08 2008-03-13 The Regents Of The University Of California Heterocyclic ligands for integrin imaging and therapy
WO2008041272A1 (en) 2006-09-29 2008-04-10 Nippon Shokubai Co., Ltd. Novel highly active modified type s-hydroxynitrile lyase
WO2008056207A1 (en) 2006-11-08 2008-05-15 Chongxi Yu Transdermal delivery systems of peptides and related compounds
CL2008000065A1 (en) 2007-01-12 2008-09-22 Smithkline Beecham Corp COMPOUNDS DERIVED FROM N-SUBSTITUTED GLYCINE, INHIBITORS OF HIF PROLIL HYDROXYLASES; YOUR PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE IN THE TREATMENT OF THE ANEMIA.
CL2008000066A1 (en) 2007-01-12 2008-08-01 Smithkline Beecham Corp COMPOUNDS DERIVED FROM (5-HYDROXY-3-OXO-2,3-DIHYDROPIRIDAZINE-4-CARBONYL) GLYCINE, HIFROXYLASE HYDROXYLASE HIF INHIBITORS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE IN THE TREATMENT OF THE ANEM
US20100105629A1 (en) 2007-03-23 2010-04-29 Bachovchin William W N-Substituted Peptidomimetic Inhibitors of Dipeptidylpeptidase IV
KR100805208B1 (en) 2007-03-27 2008-02-21 주식회사 펩트론 Exendin-containing sustained-release preparation compositions, exendin-containing sustained-release microspheres and preparation methods thereof
US8334239B2 (en) 2007-07-10 2012-12-18 The Board Of Regents Of The University Of Texas System High affinity VEGF-receptor antagonists
US8389485B2 (en) 2007-10-29 2013-03-05 University Of Massachusetts Encapsulated nanoparticles for nucleic acid delivery
KR101045130B1 (en) 2008-01-09 2011-06-30 경북대학교 산학협력단 Compound that absorbs sunlight and converts it into electrical energy and its manufacturing method
US8445632B2 (en) 2008-02-08 2013-05-21 The Regents Of The University Of California Selective poly-N-substituted glycine antibiotics
US20120295838A1 (en) 2008-02-08 2012-11-22 Barron Annelise E Selective poly-substituted glycine antibiotics and related compositions
WO2009140039A2 (en) 2008-04-23 2009-11-19 The Arizona Board Of Regents Acting For And On Behalf Of Arizona State University Synthetic antibodies
DE102008022712A1 (en) 2008-05-07 2009-11-12 Henkel Ag & Co. Kgaa Hair cleanser with fruit and / or vegetable juice
US20090318667A1 (en) 2008-05-16 2009-12-24 Kent Kirshenbaum Peptoid compositions and methods of using the same
US20100069308A1 (en) 2008-06-06 2010-03-18 Chorny Iiya Surfaces containing antibacterial polymers
JP2011525924A (en) 2008-06-25 2011-09-29 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー Prolyl hydroxylase inhibitor
WO2010014940A2 (en) * 2008-07-31 2010-02-04 Northwestern University Surface-immobilized antimicrobial peptoids
WO2010017412A1 (en) 2008-08-06 2010-02-11 The Regents Of The University Of California Novel biomimetic peptoid polymers
DE102008038137A1 (en) 2008-08-18 2010-02-25 Henkel Ag & Co. Kgaa Sulfate-free mild surfactant system for skin and hair cleansing
JP2012500802A (en) 2008-08-21 2012-01-12 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー Prolyl hydroxylase inhibitor
WO2010025087A1 (en) 2008-08-25 2010-03-04 Smithkline Beecham Corporation Prolyl hydroxylase inhibitors
US20110304329A1 (en) 2008-08-28 2011-12-15 University Of Utah Foundation Labeled peptides and methods of use thereof for improved oxidation and mapping of disulfide bridges
US8940331B2 (en) 2008-11-22 2015-01-27 The Board Of Trustees Of The Leland Stanford Junior University Hydrogels, methods of making hydrogels, methods of using hydrogels, and methods of isolating, trapping, attracting, and/or killing cancer cells
RU2011126338A (en) 2008-11-28 2013-01-10 Эбботт Лэборетриз STABLE COMPOSITIONS OF ANTIBODIES AND METHODS FOR THEIR STABILIZATION
EP2398316B1 (en) 2009-02-23 2020-01-22 Lifeline Scientific, Inc. Method for ice-free cryopreservation of tissue
US8828413B2 (en) 2009-02-24 2014-09-09 New York University Peptoid oligomers, pharmaceutical compositions and methods of using the same
WO2010111299A2 (en) 2009-03-24 2010-09-30 The Arizona Board Of Regents A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University Synthetic antibodies
EP2427476B1 (en) 2009-05-07 2018-08-08 Polyphor Ag Beta-hairpin peptidomimetics having cxcr4 antagonizing activity
KR101784528B1 (en) 2009-05-08 2017-10-12 테크필즈 바이오켐 코., 엘티디. High penetration prodrug compositions of peptides and peptide-related compounds
WO2010135277A2 (en) 2009-05-18 2010-11-25 Brown University Cyclic-glur6 analogs, methods of treatment and use
JP5991916B2 (en) 2009-05-29 2016-09-14 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム Peptoid ligand for isolation and processing of autoimmune T cells
CA2764153C (en) 2009-06-02 2021-07-27 The Board Of Regents Of The University Of Texas System Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases
US20100311036A1 (en) * 2009-06-09 2010-12-09 University Of South Carolina Methods for Augmentation of Cell Cryopreservation
US8716242B2 (en) 2009-12-04 2014-05-06 Polyphor Ag β-hairpin peptidomimetics
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
WO2011115687A2 (en) 2010-03-19 2011-09-22 Northwestern University Alkylated sp-b peptoid compounds and related lung surfactant compositions
US8461300B2 (en) 2010-03-22 2013-06-11 Sandia Corporation Materials and methods for stabilizing nanoparticles in salt solutions
US20130109627A1 (en) 2010-04-01 2013-05-02 Northwestern University Alkylated sp-c peptoid compounds and related surfactant compositions
US10081542B2 (en) 2010-04-20 2018-09-25 University of Florida Research Foundation, lnc. Nanozymes, methods of making nanozymes, and methods of using nanozymes
US8952127B2 (en) * 2010-06-04 2015-02-10 The Regents Of The University Of California Peptoids useful for catalyzing the mineralization of calcium carbonate
US9364449B2 (en) 2010-06-09 2016-06-14 New York University Peptoid and synthetic oligomers, pharmaceutical compositions and methods of using same
WO2012085586A1 (en) 2010-12-23 2012-06-28 Shire, Llc Mexiletine prodrugs
CA2824151A1 (en) 2011-01-10 2012-07-19 Opko Pharmaceuticals, Llc Antigen surrogates in autoimmune disease
BR112013024453A2 (en) 2011-03-24 2016-09-06 Opko Pharmaceuticals Llc selection of biomarkers in complex biological fluid using bead or particle-based libraries and diagnostic kits
WO2012169579A1 (en) 2011-06-07 2012-12-13 味の素株式会社 Heterocyclic carboxylic acid ester derivative
WO2013043669A1 (en) 2011-09-21 2013-03-28 The Board Of Regents Of The University Of Texas System Peptoid compositions for the treatment of alzheimer's disease and polyglutamine expansion disorder
DE102012200907A1 (en) 2012-01-23 2013-07-25 Evonik Industries Ag Method and absorption medium for absorbing CO2 from a gas mixture
KR20240116574A (en) * 2012-03-09 2024-07-29 베스타론 코포레이션 Toxic peptide production, peptide expression in plants and combinations of cysteine rich peptides
US20150126450A1 (en) 2012-04-16 2015-05-07 New York University Multivalent peptoid oligomers, pharmaceutical compositions and methods of using same
JP6653573B2 (en) 2012-05-22 2020-02-26 トラスティーズ・オブ・ダートマウス・カレッジ Methods, compounds and methods for synthesizing cycloalkanyl [b] indole, cycloalkanyl [b] benzofuran, cycloalkanyl [b] benzothiophene
US10314816B2 (en) 2012-06-08 2019-06-11 Wisconsin Alumni Research Foundation Antimicrobial compounds, compositions and methods of use thereof
DE102012013137A1 (en) 2012-07-03 2014-01-09 Häffner Gmbh & Co. Holding Kg Demarkierungsmittel
US20140100354A1 (en) 2012-10-04 2014-04-10 New York University Peptoid compositions and methods of using the same
US9598478B2 (en) * 2012-10-09 2017-03-21 Ramot At Tel-Aviv University Ltd. Peptides for the treatment of neurodegenerative diseases
DE102012221987A1 (en) 2012-11-30 2014-06-05 Henkel Ag & Co. Kgaa Coloring agent with special cationic dyes, surfactants and polymers
US20140256638A1 (en) * 2013-02-14 2014-09-11 The Regents Of The University Of California Peptoid neutralizing agents
WO2014159937A1 (en) 2013-03-13 2014-10-02 New York University Cyclic peptoid oligomers, pharmaceutical compositions and methods of using the same
TR201911139T4 (en) 2013-03-15 2019-08-21 Zymeworks Inc Cytotoxic and anti-mitotic compounds and methods of using them.
US9764953B2 (en) 2013-03-20 2017-09-19 The Regents Of The University Of California Peptoids useful for the mineralization of apatite
US20160045617A1 (en) 2013-04-10 2016-02-18 Justin C. Lee Treatment of proximal spinal muscular atrophy
US9458449B2 (en) 2013-05-20 2016-10-04 New York University Hybrid polymers, pharmaceutical compositions and methods of synthesizing the same
US10065988B2 (en) 2013-05-31 2018-09-04 Stefano Menegatti Peptoid affinity ligands
CN105377875B (en) 2013-05-31 2019-11-26 斯蒂法诺·梅内加蒂 Peptidomimetic affinity ligands for purifying antibodies or antibody fragments
CA2919226C (en) 2013-07-23 2024-05-14 Protiva Biotherapeutics, Inc. Compositions and methods for delivering messenger rna
TW201521762A (en) 2013-08-14 2015-06-16 Univ Florida Nanozymes, methods of making nanozymes, and methods of using nanozymes
US20150056142A1 (en) 2013-08-20 2015-02-26 The Board Of Trustees Of The Leland Stanford Junior University Near-infrared-ii fluorescent agents, methods of making near-infrared-ii fluorescent agents, and methods of using water-soluble nir-ii fluorescent agents
GB201317207D0 (en) 2013-09-27 2013-11-13 Univ Glasgow Materials and methods for modulating disc1 turnover
CN105814032A (en) 2013-10-10 2016-07-27 默克专利有限公司 Synthesis of 1-alkyl-2-amino-imidazol-5-carboxylic acid ester via calpha-substituted n-alkyl-glycine ester derivatives
CN106029689B (en) 2013-12-27 2021-09-28 波利弗尔股份公司 Beta-hairpin peptidomimetics as selective elastase inhibitors
KR20160130852A (en) 2014-03-19 2016-11-14 이.더블유.- 하이드로필릭 프로세시즈 엘티디 Filter
US10197575B2 (en) 2014-03-31 2019-02-05 H. Lee Moffitt Cancer Center And Research Institute, Inc. Stabilized peptoid-peptide hybrids and uses thereof
US9969773B2 (en) 2014-04-16 2018-05-15 New York University Polymers, pharmaceutical compositions and methods of synthesizing the same
GB2530479A (en) 2014-08-06 2016-03-30 Hilmar Meek Warenius Peptides useful for treating cancer
WO2016059609A1 (en) 2014-10-17 2016-04-21 Dr. Reddy' S Laboratories Limited Acylation process for preparation of liraglutide
SG11201802777XA (en) 2015-10-14 2018-05-30 X Therma Inc Compositions and methods for reducing ice crystal formation
JP7212373B2 (en) * 2017-04-12 2023-01-25 エックス－サーマ インコーポレイテッド Novel peptoid polymers and methods of use
CN118680161A (en) * 2017-04-12 2024-09-24 先时迈纳米生物科技股份有限公司 New supercooling method for preserving biological samples
WO2020018941A1 (en) * 2018-07-19 2020-01-23 The Regents Of The University Of California Peptides for activation of cell signaling in osteoprogenitor cells
CN111789099B (en) * 2019-04-09 2022-09-06 北京大学第三医院 Application of cryopreservation liquid containing peptide compounds in cryopreservation of oocytes or embryos
US20210106506A1 (en) * 2019-10-11 2021-04-15 Elc Management Llc Methods for cosmetic skin remodeling

Also Published As

Publication number Publication date
JP2022031718A (en) 2022-02-22
KR102686073B1 (en) 2024-07-17
AU2016338410B2 (en) 2021-07-15
JP2018538359A (en) 2018-12-27
IL258648A (en) 2018-06-28
HK1258922A1 (en) 2019-11-22
CN108347916B (en) 2022-02-08
EP3370518B1 (en) 2023-08-23
KR20180084782A (en) 2018-07-25
US20210100238A1 (en) 2021-04-08
US10694739B2 (en) 2020-06-30
US12137682B2 (en) 2024-11-12
WO2017066454A2 (en) 2017-04-20
EP3370518A4 (en) 2019-10-30
WO2017066454A3 (en) 2017-06-15
JP7011830B2 (en) 2022-01-27
EP3370518A2 (en) 2018-09-12
US11510407B2 (en) 2022-11-29
MX2018004518A (en) 2018-09-18
CN108347916A (en) 2018-07-31
US20230276788A1 (en) 2023-09-07
US20170295777A1 (en) 2017-10-19
CA3001065A1 (en) 2017-04-20
ES2958531T3 (en) 2024-02-09
US9986733B2 (en) 2018-06-05
US20190069537A1 (en) 2019-03-07
AU2016338410A1 (en) 2018-05-10

Similar Documents

Publication Publication Date Title
HK1258922A1 (en) Compositions and methods for reducing ice crystal formation
IL259576A (en) Compositions and methods for immunooncology
HRP20192119T8 (en) Composition and method for aiding sleep
IL253341A0 (en) Methods and compositions for combination immunotherapy
GB2535253B (en) Compositions and methods
EP3152319A4 (en) Methods and compositions for nuclease design
GB201513304D0 (en) Compositions and Methods
IL258292A (en) Methods and compositions for reducing metastases
IL246879A0 (en) Apilimod compositions and methods for using same
GB201417828D0 (en) New methods and compositions
EP2970734A4 (en) Compositions and method for refrigeration
ZA201707896B (en) Compositions and methods for reducing visual loss
HK1245158A1 (en) Apilimod compositions and methods for using same
HK1231501A1 (en) Alumina compositions and methods for producing same
HK1254550A1 (en) Compositions and methods for inhibiting beta-lactamase
HK1248236A1 (en) 6-bromo-3-hydroxy-2-pyrazinecarboxamide crystal and method for producing same
PL3113774T3 (en) Compositions of grapiprant and methods for using the same
GB201705822D0 (en) Proppant composition and method
HK1223837A1 (en) Compositions and methods for reducing overdose
GB201512996D0 (en) Compositions and methods
GB201514413D0 (en) Compositions and methods
GB201402915D0 (en) Compositions and methods
GB201518406D0 (en) Ice missile-IMFSD1
GB201516202D0 (en) Ice
GB201514415D0 (en) Compositions and methods